Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials

•IL-6 inhibitors reduce the risk of death in COVID-19 hospitalized patients.•IL-6 inhibitors decrease the odds for intubation in COVID-19 hospitalized patients.•IL-6 inhibitors increase the odds for discharge in COVID-19 hospitalized patients.•This is the first meta-analysis of individualized patien...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of internal medicine 2022-07, Vol.101, p.41-48
Hauptverfasser:	Tasoudis, Panagiotis T., Arvaniti, Christina K., Adamou, Anastasia T., Belios, Ioannis, Stone, John H., Horick, Nora, Sagris, Dimitrios, Dalekos, George N., Ntaios, George
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 Inteleukin-6 Original SOC
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!